Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia

被引:16
作者
Tessema, Sofonias K. [1 ]
Kassa, Moges [2 ]
Kebede, Amha [2 ]
Mohammed, Hussein [2 ]
Leta, Gemechu Tadesse [2 ]
Woyessa, Adugna [2 ]
Guma, Geremew Tasew [2 ]
Petros, Beyene [1 ]
机构
[1] Univ Addis Ababa, Dept Biol, Fac Sci, Addis Ababa, Ethiopia
[2] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia
来源
PLOS ONE | 2015年 / 10卷 / 10期
关键词
ANTIMALARIAL-DRUG RESISTANCE; CHLOROQUINE RESISTANCE; HIGH PREVALENCE; MOLECULAR MARKERS; MUTATIONS; MALARIA; SURVEILLANCE; PRESSURE; GENES; TRIMETHOPRIM;
D O I
10.1371/journal.pone.0126943
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Antimalarial drug resistance is one of the major challenges in global efforts of malaria control and elimination. In 1998, chloroquine was abandoned and replaced with sulfadoxine/pyrimethamine, which in turn was replaced with artemether/lumefantrine for the treatment of uncomplicated falciparum malaria in 2004. Sulfadoxine/pyrimethamine resistance is associated with mutations in dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes. The prevalence of mutation in Pfdhfr and Pfdhps genes were evaluated and compared for a total of 159 isolates collected in two different time points, 2005 and 2007/08, from Pawe hospital, in North Western Ethiopia. The frequency of triple Pfdhfr mutation decreased significantly from 50.8% (32/63) to 15.9%(10/63) (P<0.001), while Pfdhps double mutation remained high and changed only marginally from 69.2% (45/65) to 55.4% (40/65) (P = 0.08). The combined Pfdhfr/Pfdhps quintuple mutation, which is strongly associated with sulfadoxine/pyrimethamine resistance, was significantly decreased from 40.7% (24/59) to 13.6% (8/59) (P<0.0001). On the whole, significant decline in mutant alleles and re-emergence of wild type alleles were observed. The change in the frequency is explained by the reduction of residual drug-resistant parasites caused by the strong drug pressure imposed when sulfadoxine/pyrimethamine was the first-line drug, followed by lower fitness of these resistant parasites in the absence of drug pressure. Despite the decrease in the frequency of mutant alleles, higher percentages of mutation remain prevalent in the study area in 2007/08 in both Pfdhfr and Pfdhps genes. Therefore, further multi-centered studies in different parts of the country will be required to assess the re-emergence of sulfadoxine/pyrimethamine sensitive parasites and to monitor and prevent the establishment of multi drug resistant parasites in this region.
引用
收藏
页数:13
相关论文
共 44 条
  • [1] Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan
    Abdel-Muhsin, AMA
    Mackinnon, MJ
    Ali, E
    Nassir, EKA
    Suleiman, S
    Ahmed, S
    Walliker, D
    Babiker, HA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07) : 1239 - 1244
  • [2] Detection of mutations in the Plasmodium falciparum dihydrofolate reductase (dhfr) gene by dot-blot hybridization
    Abdel-Muhsin, AMA
    Ranford-Cartwright, LC
    Medani, AR
    Ahmed, S
    Suleiman, S
    Khan, B
    Hunt, P
    Walliker, D
    Babiker, HA
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 67 (01) : 24 - 27
  • [3] Short Report: Five-Year Surveillance of Molecular Markers of Plasmodium falciparum Antimalarial Drug Resistance in Korogwe District, Tanzania: Accumulation of the 581G Mutation in the P. falciparum Dihydropteroate Synthase Gene
    Alifrangis, Michael
    Lusingu, John P.
    Mmbando, Bruno
    Dalgaard, Michael B.
    Vestergaard, Lasse S.
    Ishengoma, Deus
    Khalil, Insaf F.
    Theander, Thor G.
    Lemnge, Martha M.
    Bygbjerg, Ib C.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 80 (04) : 523 - 527
  • [4] [Anonymous], 2010, WHO POL REC INT PREV
  • [5] Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials
    Aponte, John J.
    Schellenberg, David
    Egan, Andrea
    Breckenridge, Alasdair
    Carneiro, Ilona
    Critchley, Julia
    Danquah, Ina
    Dodoo, Alexander
    Kobbe, Robin
    Lell, Bertrand
    May, Juergen
    Premji, Zul
    Sanz, Sergi
    Sevene, Esperanza
    Soulaymani-Becheikh, Rachida
    Winstanley, Peter
    Adjei, Samuel
    Anemana, Sylvester
    Chandramohan, Daniel
    Issifou, Saadou
    Mockenhaupt, Frank
    Owusu-Agyei, Seth
    Greenwood, Brian
    Grobusch, Martin P.
    Kremsner, Peter G.
    Macete, Eusebio
    Mshinda, Hassan
    Newman, Robert D.
    Slutsker, Laurence
    Tanner, Marcel
    Alonso, Pedro
    Menendez, Clara
    [J]. LANCET, 2009, 374 (9700) : 1533 - 1542
  • [6] Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1
  • [7] SEQUENCE VARIATION OF THE HYDROXYMETHYLDIHYDROPTERIN PYROPHOSPHOKINASE - DIHYDROPTEROATE SYNTHASE GENE IN-LINE SO THE HUMAN MALARIA PARASITE, PLASMODIUM-FALCIPARUM, WITH DIFFERING RESISTANCE TO SULFADOXINE
    BROOKS, DR
    WANG, P
    READ, M
    WATKINS, WM
    SIMS, PFG
    HYDE, JE
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02): : 397 - 405
  • [8] AMINO-ACID CHANGES LINKED TO PYRIMETHAMINE RESISTANCE IN THE DIHYDROFOLATE-REDUCTASE THYMIDYLATE SYNTHASE GENE OF PLASMODIUM-FALCIPARUM
    COWMAN, AF
    MORRY, MJ
    BIGGS, BA
    CROSS, GAM
    FOOTE, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) : 9109 - 9113
  • [9] Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261
  • [10] Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407